Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > No follow through
View:
Post by MedStocks2 on Jan 11, 2021 1:49pm

No follow through

Another big run in the stock and a complete lack of follow through to build in this momentum. Reincorporating in the USA and listing on the US market would virtually guarantee a huge shift in trading. Instead we are left having to maintain +.60 CAD while Sigilon skyrockets. Are we watching another bad rerun?
Comment by BioTeck on Jan 11, 2021 2:35pm
Sigilon skyrockets? Really?  Looks like it's trading close to the lowest it's been. Nasdaq listing is a bad idea IMO. They will roll the shares back to get the price up. Problem here is lack of news via official channels. SVA is always propelled with rumors and inside info. Once the news eventually comes out, it's no longer news and the price suffers. Need updates on clinical ...more  
Comment by MedStocks2 on Jan 11, 2021 4:55pm
lol. Wrong chart. In any case, it seems that SGTX value is 10x Sernova without much basis for it. Just tired of waiting for news I guess. If they are cashed up now with warrants, they need to get some preclinical data out on the immune system tech.
Comment by BioTeck on Jan 12, 2021 11:35am
What makes you so sure they have pre-clinical data to release? They have been pretty low in funds for the last little while. Maybe with the exercise of warrants they can start to pull something together now but I doubt they have much else on the go other than the chicago clinical trial.  
Comment by Redbaron2211 on Jan 12, 2021 12:38pm
Agree regardless of the range SGTX has been in since the IPO it's clear SVA is massively undervalued by an order of magnitude from its peers. We are only days away from Witkowski releasing data. I'm not expecting a miracle as Philip has mentioned we won't have a binary outcome at this stage but welcome the data that will put us even further ahead of our peers and validate the next ...more  
Comment by Redbaron2211 on Jan 12, 2021 1:52pm
Would be nice to see a hault friday and resume trading on monday. IMO  
Comment by rixpix on Jan 12, 2021 2:07pm
Why would you want the stock halted if there is no real information to announce? And if there is something, announce it before the opening or after the close.
Comment by Redbaron2211 on Jan 12, 2021 2:20pm
I'm speaking to the possibility of material information.  Halt friday let them do the presentation, let a few rumors fly, release a robust update Monday morning before open.     But who am I to say doesn't really matter in the long run.  
Comment by Sonny7 on Jan 12, 2021 2:45pm
In considering Sernova’s history of hanging on to news for dear life, I’d say to write the halt idea off as a “cute” halfwit Matthews stunt. A halt to me would appear cheap as I see it if it’s trial news that is involved. Even if a trial subject was proven to be insulin independent then release the news and Let ‘er Rip.  Maybe be a different story for news of a collaboration if Sernova can ...more  
Comment by Redbaron2211 on Jan 12, 2021 3:08pm
Nothing wrong with a halt brings in attention.  IMO.  Not saying I expect one or feel its necessary but given the timelines of the presentation ext/// if you're going to drop something big getting as many ears on it as possible makes sense. Anyways we will see, I'm expecting something that will be scientifically interesting and likely wont immediately change investor sentiment ...more  
Comment by Sonny7 on Jan 12, 2021 3:16pm
Fair enough. I called it an opinion. I’m just more attracted to the foundation as opposed to spires and minarets 
Comment by BioTeck on Jan 13, 2021 12:43am
Sonny ol' chap, couldn't agree with you more.
Comment by BioTeck on Jan 12, 2021 4:40pm
There will be a NR released if there is anything material being presented. It's not that difficult releasing news and then presenting. Not sure why you'd want a halt. They are only good for blockbuster news, SVA news is going to be up for interpretation. Some people may think its good and others will think it could have been much better. The number of each will determine which way the ...more  
Comment by Redbaron2211 on Jan 12, 2021 5:13pm
Bio have you heard of the HemAcure Project?   Just happens that they are using the cell pouch for hemophilia.  Take a look at the NR last May had some great preclinical results and it will likely be progressing to the clinic in the near future and when you speak of being short on cash this is grant money. Would definitely be nice to see us entering the clinic for Hemophilia Q1 2021 ...more  
Comment by stockhunter1 on Jan 12, 2021 6:10pm
I think you will find many answers to your questions if you watch this H.C. Wainwright  Bioconnect presentation and listen well, some should listen twice!! Phillip does a great job telling our story...to be sure. This Friday and the following week should be interesting. Good Luck to ALL Longs. https://journey.ct.events/view/3a577711-041b-48a3-8b1c-0d47129bb30c     
Comment by Redbaron2211 on Jan 12, 2021 7:10pm
Thanks Stockhunter for those interested go to 8min on the video.  Re: Hemophilia "This program is moving towards the Clinic".   Other interesting tid bits.   starting with 4000 transplants is relatively small and has potential to bring in over 300 million revenue.   There are 50 million patients with TD1.   We are looking at potential revenues in the 25-30 ...more  
Comment by BioTeck on Jan 13, 2021 12:53am
What's it worth or what's it gonna cost?? Depends which pharma you ask. Stay rose rosy boy.
Comment by BioTeck on Jan 13, 2021 12:51am
Don't patronize me rose boy. Obviously I am fully aware of hemacure but that was 2 years ago. Are you aware of that? Are you also aware nothing has happened since? Are you also aware a company worth 1 billion is cashing in on what we could have done 2 years ago?
Comment by Redbaron2211 on Jan 13, 2021 8:51am
Bio they presented results on the hemophilia trials last May that's 8 moths ago. Next step is the clinic. Sure things might be slower with covid but no need to spread misinformation trying to give the impression this is a one trick pony. We all know your motives. I will stay positive, it has served me well. Cheers.
Comment by BioTeck on Jan 13, 2021 9:26am
And how long after the trial was the presentation?? You know nothing John Rose.
Comment by Redbaron2211 on Jan 13, 2021 9:44am
Bio good science takes time. I remember you were talking about how with the big money behind Semma they would be ahead of us in no time yet they haven't even started clinical trials. And why is a big company like SGTX only going after hemophilia?
Comment by stockhunter1 on Jan 13, 2021 10:44am
https://themarketherald.ca/sernova-tsxvsva-slated-to-release-clinical-trials-amid-share-price-surge-2021-01-11/ Redbaron this media write up will surely help you "stay positive" !! as we are REVALUED!!!  I find it  entertaining reading the posts from the ones with "motives" as they try and create negative sentiment constantly, not so easy to manipulate Sernova now EH ...more  
Comment by Redbaron2211 on Jan 13, 2021 2:23pm
Thanks stockhunter agree these are exciting times its nice to focus on the facts and embrace what could be a very positive out come for millions of people.
Comment by BioTeck on Jan 13, 2021 11:26pm
When does the paper from the last placement hit the street?
Comment by Redbaron2211 on Jan 14, 2021 12:05am
Jan 23rd, most that took place in the PP have a boat load of commons so I wouldn't expect that date being very significant.  If they wanted to sell commons dont need to wait for those to come free trading.
Comment by MedStocks2 on Jan 12, 2021 8:16pm
actually Red. That does make sense.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities